Breaking news: Johnson & Johnson’s coronavirus vaccine has sho | Financial Times Ukraine news

Breaking news: Johnson & Johnson’s coronavirus vaccine has shown 66% efficacy at preventing moderate and severe Covid-19, according to interim data published from a phase-3 trial of the first single-dose vaccine.